NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Other Current Assets

The latest other current assets for NRSNW is $580K as of December 2025. That compares with $860K in the prior-year period — down 32.7% year over year. Investors often review this figure alongside NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NRSNW's other current assets moved from $860K to $580K — a 32.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s operating scale or balance-sheet position.

A other current assets figure of $580K for NRSNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NRSNW's other current assets ($580K), review year-over-year change from $860K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.